Genmab A/S - Strategy and SWOT Report

Genmab A/S - Strategy and SWOT Report

is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Genmab A/S required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Genmab A/S in the form of a SWOT analysis
  • An in-depth view of the business model of Genmab A/S including a breakdown and examination of key business segments
  • Intelligence on Genmab A/S’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Genmab A/S, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Genmab (or 'the company') is a biotechnology company engaged in the discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company's therapeutic emphasis is in the areas of cancer, infectious diseases, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen, Denmark and employed 157 people as of December 31, 2013. The company recorded revenues of DKK663.6 million (approximately $118.2 million) during the financial year ended December 2013 (FY2013), an increase of 36.9% over FY2012. The operating profit of the company was DKK69.3 million (approximately $12.3 million) in FY2013, as compared to an operating loss of DKK116.7 million (approximately $20.8 million) in FY2012. The net profit of the company was DKK112.4 million (approximately $20.0 million) in FY2013, as compared to a net loss of DKK487.1 million (approximately $86.8 million) in FY2012.

Reasons to Purchase:
  • Gain understanding of Genmab A/S and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Genmab A/S as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Genmab A/S’s business structure, strategy and prospects


Company Snapshot
Genmab A/S: Company Overview
Genmab A/S: Overview and Key Facts
Genmab A/S: Overview
Genmab A/S: Key Facts
Genmab A/S: Key Employees
Genmab A/S: Key Employee Biographies
Genmab A/S: Major Products and Services
Genmab A/S: Company History
Genmab A/S: Management Statement
Genmab A/S: Locations and Subsidiaries
Genmab A/S: Key Competitors
Genmab A/S: Company Analysis
Genmab A/S: Business Description
Genmab A/S: SWOT Analysis
Genmab A/S: SWOT Overview
Genmab A/S: Strengths
Genmab A/S: Weaknesses
Genmab A/S: Opportunities
Genmab A/S: Threats
Genmab A/S: Corporate Financial Deals Activity
Genmab A/S: Financial Deals Overview
Genmab A/S: Targets and Partners
Genmab A/S: Top Deals 2011 - 2015YTD*
Genmab A/S: Capital Raising
Genmab A/S: Partnership
Genmab A/S: Divestments
Genmab A/S: Private Equity and Ownership
Genmab A/S: Recent Developments
Genmab A/S: News and Events Summary
Genmab A/S: Business Expansion
Genmab A/S: Corporate Governance
Genmab A/S: Financial Performance
Genmab A/S: Regulatory and Legal Events
Genmab A/S: Research & Development
Genmab A/S: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine
List of Tables
Table 1: Genmab A/S: Key Facts
Table 2: Genmab A/S: Key Employees
Table 4: Genmab A/S: Key Competitors
Table 5: Genmab A/S: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
Table 6: Genmab A/S: Targets and Partners
Table 7: Genmab A/S: Top Deals 2011 - 2015YTD*
Table 8: Genmab A/S: Capital Raising Volume and Value Trend (2011 - YTD*2015)
Table 9: Genmab A/S: Capital Raising by Deal Type (2011 - YTD*2015)
Table 10: Genmab A/S: Partnership Volume and Value Trend (2011 - YTD*2015)
Table 11: Genmab A/S: Partnership Trend by Deal Type (2011 - YTD*2015)
Table 12: Genmab A/S: Divestments Volume and Value Trend (2011 - YTD*2015)
Table 13: Genmab A/S: Divestments by Geography (2011 - YTD*2015)
Table 14: Genmab A/S: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
Table 15: Genmab A/S: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)
Table 16: Genmab A/S: News and Events Summary
Table 17: Genmab A/S: Business Expansion
Table 18: Genmab A/S: Corporate Governance
Table 19: Genmab A/S: Financial Performance
Table 20: Genmab A/S: Regulatory and Legal Events
Table 21: Genmab A/S: Research & Development
Table 22: Genmab A/S: Strategy and Operations
List of Figures
Figure 1: Genmab A/S: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
Figure 2: Genmab A/S: Capital Raising Volume and Value Trend (2011 - YTD*2015)
Figure 3: Genmab A/S: Capital Raising by Deal Type (2011 - YTD*2015)
Figure 4: Genmab A/S: Partnership Volume and Value Trend (2011 - YTD*2015)
Figure 5: Genmab A/S: Partnership Trend by Deal Type (2011 - YTD*2015)
Figure 6: Genmab A/S: Divestments Volume and Value Trend (2011 - YTD*2015)
Figure 7: Genmab A/S: Divestments by Geography (2011 - YTD*2015)
Figure 8: Genmab A/S: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
Figure 9: Genmab A/S: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook